ERS 2019, Madrid

The annual ERS Congress is a showcase of excellence across the entire field of respiratory Medicine. ERS International Congress 2019 was hosted in Madrid, Spain from 28 September to 2 October 2019 at IFEMA. This year, the Congress gathered more than 20,000 delegates over five days to witness more than ...

Novalung GmbH, which specialises in solutions for respiratory failure, was absorbed into Xenios AG on 30 August 2019. Processes will be streamlined as a result and the company will become more closely aligned with the parent company Fresenius Medical Care. Novalung was established in 2003 and specialises in the treatment ...

Synchronized cardiovascular support now ready for the market

Xenios AG concludes its first clinical study on i-cor Synchronized Cardiac Assist, documenting the safety and feasibility of the synchronized cardiovascular support system. During the “SynCor” trial, a multicentre study treated 47 patients in nine different German clinics using an innovative pulsatile, cardiac-synchronous circulatory support system. The aim of the ...

Relaunch of the Xenios Website – now harmonized with that of its parent, Fresenius Medical Care

The Xenios AG, pioneer in extracorporeal heart and lung support, has restructured its website. Xenios AG has been part of the Fresenius Medical Care Group since 2016 and the new design also serves to bring the company visually in line with the brand image of its parent. www.xenios-ag.com With this ...

View our latest brochure Heart and Lung Assist for Pediatric Patients

View our latest brochure Heart and Lung Assist for Pediatric Patients.

Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019

Shaping the future of multi organ support – Novalung and Fresenius Medical Care at the ISICEM Brussels 2019.